Patent · US Active

Compounds and compositions as inhibitors of MEK

US9227969B2 · kind B2 · utility

1Cited by

2References

16Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Mark G. Bock · Hatfield, US
Henrik Moebitz · Glückstadt, DE
Sunil Kumar Panigrahi · Dashapalla, IN
Ramulu Poddutoori · Karimnagar, IN
Susanta Samajdar · Savanuru, IN

Key dates

Filing date	Aug 5, 2014
Grant date	Jan 5, 2016
Priority date	—
Expiry date	Aug 5, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.